Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case-case study

Sabri Atalay1, Derya Çağlayan2, Eren Arkalı3

  • 1Department of Infectious Diseases and Clinical Microbiology, Tepecik Training and Research Hospital, Izmir, Turkey.

Mycoses
|March 28, 2024
PubMed
Abstract

Insights

Fluconazole resistance in Candida parapsilosis bloodstream infections is linked to intra-abdominal surgery, low albumin levels, and prior fluconazole use in intensive care units. Continuous monitoring and antifungal stewardship are recommended.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Critical Care Medicine

Background:

  • Candida species are leading invasive pathogens in intensive care units (ICUs).
  • Non-albicans Candida species, particularly Candida parapsilosis (C. parapsilosis), are increasingly prevalent.
  • Fluconazole resistance in C. parapsilosis poses a significant clinical challenge.

Purpose of the Study:

  • To identify factors associated with fluconazole resistance in C. parapsilosis candidemia.
  • To investigate predictors of fluconazole-resistant C. parapsilosis bloodstream infections in ICU patients.

Main Methods:

  • A case-case study design comparing fluconazole-resistant and fluconazole-susceptible C. parapsilosis candidemia.
  • Data collected from 2015-2021 at a tertiary hospital.
  • Logistic regression analysis, including backward elimination, to determine independent predictors.

Main Results:

  • Out of 177 patients, 43% had fluconazole-resistant C. parapsilosis isolates.
  • Univariate analysis identified malignancy, immunosuppressive treatment, intra-abdominal surgery, hypoalbuminemia, previous fluconazole use, and SOFA score as risk factors.
  • Multivariate analysis revealed intra-abdominal surgery (OR: 2.16), hypoalbuminemia (OR: 2.56), and previous fluconazole use (OR: 3.35) as independent predictors.

Conclusions:

  • Intra-abdominal surgery, hypoalbuminemia, and prior fluconazole use are significantly correlated with fluconazole-resistant C. parapsilosis candidemia in ICUs.
  • Continuous monitoring of C. parapsilosis isolates and antifungal resistance is crucial.
  • Implementation of strict infection control and antifungal stewardship programs is recommended.